# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.6...
RBC Capital analyst Shagun Singh maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from...
Mizuho analyst Anthony Petrone maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $95 to $...